Bcl-7c inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the Bcl-7c protein, a member of the Bcl-7 family of proteins known for their involvement in regulating chromatin remodeling and gene transcription. Bcl-7c plays a role in modulating the structure and accessibility of chromatin, which in turn influences the expression of various genes critical for cell growth, differentiation, and survival. By inhibiting Bcl-7c, these compounds interfere with its ability to participate in the processes that control chromatin dynamics, potentially altering the transcriptional landscape within the cell. This makes Bcl-7c inhibitors important tools for studying how changes in chromatin structure affect gene expression and cellular function.
The chemical architecture of Bcl-7c inhibitors is typically designed to target specific functional domains of the Bcl-7c protein, disrupting its interaction with other components of the chromatin remodeling machinery. These inhibitors are often developed through structure-activity relationship (SAR) studies to optimize their specificity for Bcl-7c, ensuring that they effectively block its activity without affecting related proteins. Through the inhibition of Bcl-7c, researchers can investigate the precise role this protein plays in maintaining chromatin architecture and regulating gene transcription. Furthermore, Bcl-7c inhibitors provide a valuable means of exploring how alterations in chromatin structure impact broader cellular processes such as DNA replication, repair, and overall genome stability. This contributes to a deeper understanding of the molecular mechanisms that control chromatin dynamics and their significance in the regulation of gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
Targets Bcl-2, an anti-apoptotic member of the Bcl-2 family, which might indirectly influence Bcl-7c activity. | ||||||
ABT 263 | 923564-51-6 | sc-207241 | 5 mg | $245.00 | 16 | |
Inhibits both Bcl-2 and Bcl-xL; its impact on Bcl-2 might indirectly influence Bcl-7c. | ||||||
ABT 737 | 852808-04-9 | sc-207242 | 2.5 mg | $204.00 | 54 | |
Targets Bcl-2, Bcl-xL, and Bcl-w; affecting these can indirectly modulate Bcl-7c associated pathways. | ||||||
WEHI-539 | 1431866-33-9 | sc-507317 | 5 mg | $233.00 | ||
A selective Bcl-xL inhibitor; the inhibition of related proteins can impact the function of Bcl-7c. | ||||||
Sabutoclax | 1228108-65-3 | sc-472977 | 1 mg | $330.00 | ||
Pan-Bcl-2 inhibitor, affecting multiple Bcl-2 family members which might indirectly influence Bcl-7c's function. | ||||||
Obatoclax Mesylate | 803712-79-0 | sc-364221 sc-364221A | 5 mg 10 mg | $96.00 $141.00 | ||
Targets multiple Bcl-2 family proteins, and its broad-spectrum action might indirectly influence Bcl-7c. | ||||||
TW-37 | 877877-35-5 | sc-361387 sc-361387A | 10 mg 50 mg | $200.00 $860.00 | 2 | |
Targets Bcl-2, Bcl-xL, and Mcl-1; its broad targeting might have indirect implications on Bcl-7c functions. | ||||||
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $116.00 $230.00 | 12 | |
Natural Bcl-2 inhibitor that can indirectly impact pathways where Bcl-7c is active. | ||||||
HA14-1 | 65673-63-4 | sc-205911 sc-205911A | 5 mg 25 mg | $59.00 $209.00 | ||
Bcl-2 inhibitor, affecting apoptotic pathways, can indirectly influence the pathways Bcl-7c is associated with. | ||||||
S63845 | 1799633-27-4 | sc-507518 | 1 mg | $150.00 | ||
Targets Mcl-1, and its influence on this Bcl-2 family member can have repercussions on Bcl-7c-related processes. | ||||||